OXIDATIVE REDUCTIVE CONJUGATION OF MANNAN TO ANTIGEN SELECTS FOR T-1 OR T-2 IMMUNE-RESPONSES

被引:189
作者
APOSTOLOPOULOS, V [1 ]
PIETERSZ, GA [1 ]
LOVELAND, BE [1 ]
SANDRIN, MS [1 ]
MCKENZIE, IFC [1 ]
机构
[1] AUSTIN RES INST,HEIDELBERG,VIC 3084,AUSTRALIA
关键词
MUCIN; CYTOTOXIC T LYMPHOCYTES; IMMUNOTHERAPY; CANCER;
D O I
10.1073/pnas.92.22.10128
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The induction of CD8(+) cytotoxic T lymphocytes (CTLs) is desirable for immunization against many diseases, and recombinant-synthetic peptide antigens are now favored agents to use, However, a major problem is how to induce CTLs, which requires a T-1-type response to such synthetic antigens. We report that T-1-type (generating high CTL, low antibody) or T-2-type (the reciprocal) responses can be induced by conjugation of the antigen to the carbohydrate polymer mannan: T-1 responses are selected by using oxidizing conditions; T-2 responses are selected by using reducing conditions for the conjugation. Using human MUC1 as a model antigen in mice, immunization with oxidized mannan-MUC1 fusion protein (ox-M-FP) led to complete tumor protection (challenge up to 5 x 10(7) MUC1(+) tumor cells), CTLs, and a high CTL precursor (CTLp) frequency (1/6900), whereas immunization with reduced mannan-MUC1 FP (red-M-FP) led to poor protection after challenge with only 10(6) MUC1(+) tumor cells, no CTLs, and a low CTLp frequency (1/87,800). Ox-M-FP selects for a T-1 response (mediated here by CD8(+) cells) with high interferon gamma (IFN-gamma) secretion, no interleukin 4 (IL-4), and a predominant IgG2a antibody response; red-M-FP selects for a T-2-type response with IL-4 production and a high predominant IgG1 antibody response but no IFN-gamma.
引用
收藏
页码:10128 / 10132
页数:5
相关论文
共 31 条
  • [1] VACCINIA VIRUS MUC1 IMMUNIZATION OF MICE - IMMUNE-RESPONSE AND PROTECTION AGAINST THE GROWTH OF MURINE TUMORS BEARING THE MUC1 ANTIGEN
    ACRES, RB
    HAREUVENI, M
    BALLOUL, JM
    KIENY, MP
    [J]. JOURNAL OF IMMUNOTHERAPY, 1993, 14 (02) : 136 - 143
  • [2] APOSTOLOPOULOS V, 1994, CANCER RES, V54, P5186
  • [3] PRODUCTION OF ANTI-BREAST CANCER MONOCLONAL-ANTIBODIES USING A GLUTATHIONE-S-TRANSFERASE-MUC1 BACTERIAL FUSION PROTEIN
    APOSTOLOPOULOS, V
    XING, PX
    TRAPANI, JA
    MCKENZIE, IFC
    [J]. BRITISH JOURNAL OF CANCER, 1993, 67 (04) : 713 - 720
  • [4] DIFFERENTIATION ANTIGENS EXPRESSED BY EPITHELIAL-CELLS IN THE LACTATING BREAST ARE ALSO DETECTABLE IN BREAST CANCERS
    ARKLIE, J
    TAYLORPAPADIMITRIOU, J
    BODMER, W
    EGAN, M
    MILLIS, R
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1981, 28 (01) : 23 - 29
  • [5] SPECIFIC, MAJOR HISTOCOMPATIBILITY COMPLEX - UNRESTRICTED RECOGNITION OF TUMOR-ASSOCIATED MUCINS BY HUMAN CYTO-TOXIC T-CELLS
    BARND, DL
    LAN, MS
    METZGAR, RS
    FINN, OJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (18) : 7159 - 7163
  • [6] THE EVALUATION OF LIMITING DILUTION ASSAYS
    DESTGROTH, SF
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1982, 49 (02) : R11 - R23
  • [7] IMMUNOGENICITY OF SYNTHETIC PEPTIDES RELATED TO THE CORE PEPTIDE SEQUENCE ENCODED BY THE HUMAN MUC1 MUCIN GENE - EFFECT OF IMMUNIZATION ON THE GROWTH OF MURINE MAMMARY ADENOCARCINOMA CELLS TRANSFECTED WITH THE HUMAN MUC1 GENE
    DING, L
    LALANI, E
    REDDISH, M
    KOGANTY, R
    WONG, T
    SAMUEL, J
    YACYSHYN, MB
    MEIKLE, A
    FUNG, PYS
    TAYLORPAPADIMITRIOU, J
    LONGENECKER, BM
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1993, 36 (01) : 9 - 17
  • [8] CHARACTERIZATION OF CANDIDA-ALBICANS MANNAN-INDUCED, MANNAN-SPECIFIC DELAYED-HYPERSENSITIVITY SUPPRESSOR CELLS
    GARNER, RE
    CHILDRESS, AM
    HUMAN, LG
    DOMER, JE
    [J]. INFECTION AND IMMUNITY, 1990, 58 (08) : 2613 - 2620
  • [9] Harisch F. G., 1989, J BIOL CHEM, V264, P872
  • [10] IOANNIDES CG, 1993, J IMMUNOL, V151, P3693